382 related articles for article (PubMed ID: 35181312)
1. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis.
Singh D; Khan MA; Siddique HR
Biochem Pharmacol; 2022 Apr; 198():114955. PubMed ID: 35181312
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
[TBL] [Abstract][Full Text] [Related]
3. Bidirectional Crosstalk Between Cancer Stem Cells and Immune Cell Subsets.
Müller L; Tunger A; Plesca I; Wehner R; Temme A; Westphal D; Meier F; Bachmann M; Schmitz M
Front Immunol; 2020; 11():140. PubMed ID: 32117287
[TBL] [Abstract][Full Text] [Related]
4. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
5. Current understanding of cancer stem cells: Immune evasion and targeted immunotherapy in gastrointestinal malignancies.
An J; Hu X; Liu F
Front Oncol; 2023; 13():1114621. PubMed ID: 36910604
[TBL] [Abstract][Full Text] [Related]
6. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
[TBL] [Abstract][Full Text] [Related]
7. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
8. Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy.
Borlongan MC; Saha D; Wang H
Stem Cell Rev Rep; 2024 Jan; 20(1):3-24. PubMed ID: 37861969
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
[TBL] [Abstract][Full Text] [Related]
10. Immune evader cancer stem cells direct the perspective approaches to cancer immunotherapy.
Dianat-Moghadam H; Mahari A; Salahlou R; Khalili M; Azizi M; Sadeghzadeh H
Stem Cell Res Ther; 2022 Apr; 13(1):150. PubMed ID: 35395787
[TBL] [Abstract][Full Text] [Related]
11. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
[TBL] [Abstract][Full Text] [Related]
12. Influence of Innate Immunity on Cancer Cell Stemness.
Pastò A; Consonni FM; Sica A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
[TBL] [Abstract][Full Text] [Related]
13. The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure.
Galassi C; Musella M; Manduca N; Maccafeo E; Sistigu A
Cells; 2021 Sep; 10(9):. PubMed ID: 34572009
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cells and their Management in Cancer Therapy.
Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
16. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
17. The role of stem cells in small-cell lung cancer: evidence from chemoresistance to immunotherapy.
Guo W; Qiao T; Li T
Semin Cancer Biol; 2022 Dec; 87():160-169. PubMed ID: 36371027
[TBL] [Abstract][Full Text] [Related]
18. Cancer stem cell-immune cell crosstalk in the tumor microenvironment for liver cancer progression.
Ma Y; Lv H; Xing F; Xiang W; Wu Z; Feng Q; Wang H; Yang W
Front Med; 2024 Jun; 18(3):430-445. PubMed ID: 38600350
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal relationship between cancer stem cells and myeloid-derived suppressor cells: implications for tumor progression and therapeutic strategies.
Ding G; Yu H; Jin J; Qiao X; Ma J; Zhang T; Cheng X
Future Oncol; 2024 Feb; 20(4):215-228. PubMed ID: 38390682
[TBL] [Abstract][Full Text] [Related]
20. Translational potential of cancer stem cells: A review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment.
Islam F; Gopalan V; Smith RA; Lam AK
Exp Cell Res; 2015 Jul; 335(1):135-47. PubMed ID: 25967525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
